FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

View source ↗

Summary

FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG, indicating an approved modification to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obsessive-compulsive Disorder
• Panic Disorder
• Post-traumatic Stress Disorder
• Premenstrual Dysphoric Disorder
• Social Anxiety Disorder

Drugs mentioned

• Zoloft (sertraline)

Snippet

SUPPL AP for ZOLOFT (SERTRALINE HYDROCHLORIDE)